Coricidin HBP Cold & Flu MSD Consumer Care 11523432502-Coricidin HBP Cold & Flu Acetaminophen / Chlo

Comprehensive Cold Relief for Sensitive Individuals
Coricidin HBP Cold & Flu offers a specially formulated relief solution for individuals who suffer from high blood pressure. This product is designed to soothe cold and cough symptoms without the risk of added decongestants, making it a safe choice for sensitive users. Each tablet combines effective ingredients ensuring that you can tackle your cold symptoms without compromising your health conditions, thus allowing you to continue with your daily activities.

Effective Ingredients for Symptom Management
The core of Coricidin HBP Cold & Flu is its unique blend of active ingredients. Each tablet contains 325 milligrams of acetaminophen, known for its efficacy in pain relief and fever reduction. It also features 2 milligrams of chlorpheniramine maleate, an antihistamine that alleviates allergy symptoms such as a runny nose or sneezing. This dual-action formula addresses the discomfort associated with colds while maintaining safety for those with specific health concerns.

Convenient Packaging and Dosing
This product is packaged in a box containing 20 coated tablets, ensuring that you have an ample supply for when cold symptoms strike. The coated design of the tablets facilitates easier consumption and absorption, making it a convenient option for users. Whether at home or on the go, Coricidin HBP Cold & Flu is designed to be part of your cold relief regimen, providing effective relief whenever you need it most.

Quality Assurance and Accessibility
As part of the analgesics category, Coricidin HBP Cold & Flu adheres to strict quality standards to provide you with a reliable product. The formulation is designed with the consumer�s health and safety in mind, particularly for those managing high blood pressure conditions. Users can confidently choose Coricidin as a trusted partner in managing their cold symptoms without the worry of added decongestants, further enhancing its accessibility to a wider audience.